Helth & tips, &; Technology tips: Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients

Monday, July 13, 2020

Biocon's Covid-19 Drug Itolizumab Approved for Emergency Use after Trial on Only 30 Patients

Itolizumab is an existing drug used to treat skin ailment Psoriasis. The Drug Controller General of India (DCGI) approved its restricted emergency use on Saturday.

from Top India News- News18.com https://ift.tt/32dxt1A

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home